Sanofi CEO: "AI is a huge opportunity and we can't be deniers"
Sanofi CEO Paul Hudson says, "AI is a huge opportunity, and we can't be deniers." ...
Pharmaceutical Technology44m
Sanofi’s combo vaccines gain FDA fast track designation
Sanofi has announced that its two combination vaccine candidates have received fast track status from the US FDA.
Monroe County's Sanofi plant fast-tracked for combination COVID/flu vaccine approval
The US Food and Drug Administration(FDA) has granted Fast Track designation to two non-mRNA combination vaccine candidates ...
Sanofi’s Phase III trial of rilzabrutinib for thrombocytopenia meets endpoint
Sanofi has reported that the Phase III LUNA 3 trial of rilzabrutinib for the treatment of persistent or chronic immune ...
Most RSV infections are in babies less than 1 year old. But protection remains out of reach for many
Most positive tests for RSV so far this season in Canada have been among the youngest, federal data says. And while Health ...
STAT4d
Sanofi advances a drug for a rare, platelet-destroying disease
A drug developed by Sanofi raised platelet counts and reduced bleeding episodes in patients with a rare autoimmune disorder ...
Daily1d
Two Sanofi combination vaccine candidates for prevention of influenza, COVID gets USFDA Fast Track designation
Paris: The US Food and Drug Administration (USFDA) has granted Fast Track designation to two Sanofi combination vaccine ...
Sanofi says Sarclisa combos showed benefits in multiple myeloma patients
Sanofi (SNY) says new data from three oral presentations demonstrated significant clinical benefit with Sarclisa-based quadruplets in newly ...
FiercePharma5d
Fierce Pharma Asia—Sanofi's $1B manufacturing base; GSK's ADC deal, Shingrix recalibration in China
Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF) and NovoCure (NVCR)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and ...
Pharmabiz4h
US FDA grants fast track designation to two Sanofi’s combination vaccine candidates to prevent influenza & Covid-19 infections
US FDA grants fast track designation to two Sanofi’s combination vaccine candidates to prevent influenza & Covid-19 infections: Paris Thursday, December 12, 2024, 10:00 Hrs [IST ...
HighTower Advisors LLC Purchases 848 Shares of Sanofi (NASDAQ:SNY)
HighTower Advisors LLC boosted its position in Sanofi (NASDAQ:SNY – Free Report) by 1.0% during the 3rd quarter, according to ...